SCHEMBL23313715

SCHEMBL23313715

c1ccc(-c2cc(Nc3ccc4c(c3)oc3ccccc34)cc(-c3cccc4c3sc3ccccc34)c2)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 1/20 0.41
PRKDC P78527 3/20 0.41
NPSR1 Q6W5P4 1/20 0.36
EPHX2 P34913 1/20 0.36
KMT2A Q03164 6/20 0.35
SMN1; SMN2 Q16637 6/20 0.35
MEN1 O00255 5/20 0.35
ALDH1A1 P00352 5/20 0.35
L3MBTL1 Q9Y468 2/20 0.35
POLB P06746 1/20 0.35
NPC1 O15118 4/20 0.35
RAB9A P51151 4/20 0.35
GAA P10253 3/20 0.35
DUSP3 P51452 1/20 0.35
KDM4E B2RXH2 4/20 0.34
LMNA P02545 3/20 0.34
TP53 P04637 2/20 0.34
HTT P42858 1/20 0.34
PARP14 Q460N5 1/20 0.34
HPGD P15428 3/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23313947 0.86 ALOX5 (0.39) ALOX5PRKDCNPSR1KMT2ASMN1; SMN2
SCHEMBL17550922 0.85 ALOX5 (0.44) ALOX5PRKDCEPHX2PARP14PIK3CD
SCHEMBL27383948 0.84 ALOX5 (0.53) ALOX5PRKDCEPHX2KMT2AMEN1
SCHEMBL23314002 0.83 ALOX5 (0.41) ALOX5PRKDCEPHX2KMT2ASMN1; SMN2
SCHEMBL17550955 0.83 ALOX5 (0.52) ALOX5PRKDCEPHX2PARP14PIK3CD
SCHEMBL19239182 0.82 NPSR1 (0.48) NPSR1EPHX2KMT2ASMN1; SMN2MEN1
SCHEMBL23372938 0.81 PRKDC (0.40) ALOX5PRKDCNPSR1EPHX2KMT2A
SCHEMBL21239160 0.81 PRKDC (0.45) ALOX5PRKDCKMT2ASMN1; SMN2MEN1
SCHEMBL21261129 0.81 PRKDC (0.45) ALOX5PRKDCPARP14PIK3CDBRD4
SCHEMBL21261135 0.81 PRKDC (0.45) ALOX5PRKDCKMT2ASMN1; SMN2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210126197-A1 ORGANIC ELECTROLUMINESCENCE DEVICE AND AMINE COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2021-04-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210126197-A1 ORGANIC ELECTROLUMINESCENCE DEVICE AND AMINE COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE PIEZO1, L1CAM, AOC1 ALOX5 1383/4885PRKDC 3926/4885NPSR1 1709/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.